Latest Sustainability In It News

Eastern Resources Limited's December 2024 quarterly cash flow report reveals a modest operating cash outflow amid ongoing exploration expenses, supported by a healthy cash reserve expected to sustain operations for over 19 quarters.

Toubani Resources' December quarterly report confirms the Kobada Gold Project as a major gold development with robust financials and progressing government engagement in Mali. The company is advancing permitting and financing efforts as it targets shovel-ready status in 2025.

Norwest Minerals reports significant silver, lead, zinc, and copper intersections at its West Arunta project, while advancing gold exploration at Bulgera and planning further drilling campaigns.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Hydrix Limited reports back-to-back profitable quarters driven by strong margins and cost efficiencies, underpinned by a robust $40 million sales opportunity pipeline in cardiac and medtech sectors.

Bowen Coking Coal reported a strong December quarter with record coal sales and a 39% reduction in cash costs, underpinning a $29 million EBITDA despite softer coal prices.

XPON Technologies reports a modest 2% increase in martech revenue and a strong cash position for Q2 FY25, while navigating an 8% decline in annualised recurring revenue amid strategic sales recalibration.

Nuix projects solid growth in Annualised Contract Value and revenue for the first half of FY25, despite elongated procurement timelines and increased contract complexity.

Energy Resources of Australia Limited reported a substantial net cash outflow of $183.9 million in Q4 2024, driven by significant rehabilitation payments, while raising $766.5 million through equity to bolster its cash position.

Dropsuite Limited posted a standout quarter with a 37% rise in annual recurring revenue and a 42% jump in paid users, underscoring the strength of its partner ecosystem and product innovation.

IDT Australia reports a near doubling of quarterly revenue to $5.3 million, driven by explosive growth in its Advanced Therapies segment, with first-half revenue expected to jump 82%.

Bioxyne Limited reports a remarkable 77% revenue increase in Q2 FY2025 alongside positive operating cash flow, setting the stage for international growth with upcoming UK export approvals and a planned European GMP facility.